Publication:
Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA Collaboration

Simple item page
dc.contributor.authorsOrnbjerg, Lykke Midtboll; Askling, Johan; Loft, Anne Gitte; Nissen, Michael J.; Mann, Herman; Direskeneli, Haner; Iannone, Florenzo; Sexton, Joe; Nordstrom, Dan; Santos, Maria Jose; Codreanu, Catalin; Pombo-Suarez, Manuel; Rotar, Ziga; Gudbjornsson, Bjorn; Van der Horst-Bruinsma, Irene; Lindstrom, Ulf; Ciurea, Adrian; Pavelka, Karel; Yilmaz, Neslihan; Gremese, Elisa; Kristianslund, Eirik; Hokkanen, Anna Mari; Barcelos, Anabela; Ionescu, Ruxandra; Sanchez-Piedra, Carlos; Tomsic, Matija; Geirsson, Arni Jon; van de Sande, Marleen; Macfarlane, Gary; Brahe, Cecilie Heegaard; Hetland, Merete Lund; Ostergaard, Mikkel
dc.date.accessioned2022-03-10T18:00:10Z
dc.date.accessioned2026-01-11T16:45:06Z
dc.date.available2022-03-10T18:00:10Z
dc.date.issued2019
dc.identifier.doidoiWOS:000507466901506
dc.identifier.eissn2326-5205
dc.identifier.issn2326-5191
dc.identifier.urihttps://hdl.handle.net/11424/222268
dc.identifier.wosWOS:000507466901506
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofARTHRITIS & RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titlePatient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA Collaboration
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.titleARTHRITIS & RHEUMATOLOGY
oaire.citation.volume71

Files

Collections

Araştırma Çıktıları